Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
Clinical trial NCT03210649 · COMPLETED
Trial details
- NCT number
- NCT03210649
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2017-04-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.